Krystal Biotech completes IPO
September 22, 2017 at 14:19 PM EDT
The Pittsburgh-based gene therapy startup's aggregate gross proceeds were $45.5 million.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.